Terns Pharmaceuticals, Inc.
TERN
$52.63
$0.070.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.13% | -12.26% | -5.97% | -6.86% | -3.71% |
| Total Depreciation and Amortization | -47.20% | -46.12% | -55.00% | -28.39% | -2.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 39.57% | -11.45% | -21.08% | 14.46% | 66.79% |
| Change in Net Operating Assets | -87.13% | -6.51% | -16.23% | -13.00% | 2,745.34% |
| Cash from Operations | -30.85% | -20.16% | -16.69% | -7.20% | 24.50% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -270.97% | -22.83% | -39.58% | -75.59% | -299.57% |
| Cash from Investing | -270.97% | -22.83% | -39.56% | -75.50% | -299.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 120,377.80% | -100.00% | -18.80% | -- | -95.55% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 26.84% | 100.00% | -- | -- | -- |
| Cash from Financing | 244,347.04% | -100.00% | -18.80% | -- | -97.81% |
| Foreign Exchange rate Adjustments | 121.74% | -90.57% | 92.86% | 88.46% | -127.06% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 444.12% | -97.35% | -73.70% | -51.18% | -358.60% |